Xeris Biopharma Holdings, Inc. XERS Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s other income, net (note 6)?
- Xeris Biopharma Holdings, Inc. (XERS) reported other income, net (note 6) of -$5.68M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s other income, net (note 6) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s other income, net (note 6) increased by 7.3% year-over-year, from -$6.13M to -$5.68M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s other income, net (note 6)?
- Over 3 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s other income, net (note 6) has grown at a 47.6% compound annual growth rate (CAGR), from -$7.57M to -$24.34M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.